"İstanbul Üniversitesi İstanbul Tıp Fakültesi Türkiye'nin sağlık eğitiminde öncü üniversitesi olarak Evrensel standartlara sahip nitelikli hekimler ve bilim insanları yetiştiren, ülkemize ve insanlığa yararlı bilgi üreten, kaliteli sağlık hizmeti sunan ve bu işlevleri etkin şekilde koordine eden öncü bir kurum olmak misyonuyla eğitim vermektedir."

During the past decade, Istanbul University Istanbul School of Medicine; Neurology conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 9 clinical trials were completed, i.e. on average, 26.5% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 6 clinical trials were completed. i.e. 31.6% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Istanbul University Istanbul School of Medicine; Neurology" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Istanbul University Istanbul School of Medicine; Neurology" are "Alzheimer's Disease" (4 trials), "Alzheimer Disease" (2 trials), "Aortic Diseases" (2 trials), "Breast Cancer" (2 trials) and "COVID-19" (2 trials). Many other conditions were trialed in "Istanbul University Istanbul School of Medicine; Neurology" in a lesser frequency.

Most popular intervention types in "Istanbul University Istanbul School of Medicine; Neurology" are "Drug" (21 trials), "Device" (8 trials), "Other" (8 trials), "Behavioral" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Gantenerumab" (4 trials), "CoronaVac" (3 trials), "Ocrelizumab" (3 trials) and "Crenezumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Istanbul University Istanbul School of Medicine; Neurology" are 38 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are 12 active trials in "Istanbul University Istanbul School of Medicine; Neurology". 1 are not yet recruiting, 5 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 23 completed trials in Istanbul University Istanbul School of Medicine; Neurology, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Istanbul University Istanbul School of Medicine; Neurology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 19 trials that are defined as “Not Applicable".